Antihypertensive Therapeutics Market Vendor Analysis, Forecast and Investment Trends to 2020

Antihypertensive Therapeutics Market Size, Share, Trends, Company

Profiles, Demand, Insights, Analysis, Research, Report, Opportunities,

Segmentation and Forecast To 2020

Hypertension is a heart-related disease which results in elevated blood pressure in the arteries. It

is also known as arterial hypertension or high blood pressure. This disease occurs on account of

alcohol, smoking, obesity, and other genetic factors. Although, the disease can be treated with a

healthy diet and exercise, antihypertensives are recommended to control it.

Antihypertensives are a class of drugs which can prevent hypertension and other cardiovascularrelated disorders like strokes and myocardial infarction. They are likely to reduce the heart

conditions by 21%. Beta blockers, thiazide diuretics, ACE inhibitors, calcium channel blockers,

and angiotensin II receptor antagonists (ARBs) are the different types of antihypertensive

therapeutics in major developed markets.

Thiazide diuretics aid in reducing salt and water from the kidneys. They are the first drugs to be

administered for a patient undergoing hypertension treatment. ACE inhibitors reduce serum

creatinine levels better than beta blockers. They are considered the first line of defense against

heart-related disorders. ARBs reduces the risko f myocardial infarction when combined with

amlodipine. Beta blockers are considered risky and can lead to strokes or type-2 diabetes.

However, they prevent heart attacks in persons who have already experienced a heart attack.

To Get More Details @ http://www.radiantinsights.com/research/antihypertensivetherapeutics-in-major-developed-markets-to-2020-increased-uptake-of-combinationtherapies-to-offset-effects-of-key-patent-expiries

The hypertension market was estimated to have earned USD 40 billion of revenue in 2013. The

market will attain USD 37 billion by 2020, owing to the patent expiry of major drugs. It is

predicted to grow at a 2.6% CAGR during the period of 2014 to 2017. The market will...